• Ionis Pharmaceuticals (IONS) Is Up 8.6% After Groundbreaking Study Results in Alexander Disease Therapy - What’s Changed simplywall.st Fri, 03 Oct 2025 12:16:48 GMT
• Why ETFs are accumulating Ionis Pharmaceuticals Inc. (ISI) stock - July 2025 Intraday Action & Community Consensus Trade Alerts newser.com Fri, 03 Oct 2025 11:52:44 GMT
• Applying big data sentiment scoring on Ionis Pharmaceuticals Inc. - Trade Risk Report & Capital Efficiency Focused Ideas newser.com Fri, 03 Oct 2025 07:39:06 GMT
• Is Ionis Pharmaceuticals Inc. building a consolidation base - July 2025 Highlights & Entry Point Confirmation Signals newser.com Fri, 03 Oct 2025 06:26:29 GMT
• Should you hold or exit Ionis Pharmaceuticals Inc. now - July 2025 Market Mood & Weekly Momentum Picks newser.com Fri, 03 Oct 2025 03:38:05 GMT
• Insider Sell Alert: Patrick O'neil Sells 64,664 Shares of Ionis Pharmaceuticals Inc (IONS) GuruFocus Fri, 03 Oct 2025 02:18:05 GMT
• Is Ionis Pharmaceuticals Inc. (ISI) stock a fit for income portfolios - July 2025 PostEarnings & Precise Buy Zone Identification newser.com Fri, 03 Oct 2025 01:23:24 GMT
• applying big data sentiment scoring on ionis pharmaceuticals inc. - 2025 fundamental recap & technical buy zone confirmations newser.com Thu, 02 Oct 2025 23:41:01 GMT
• Ionis Pharmaceuticals(IONS.US) Officer Sells US$4.38 Million in Common Stock 富途牛牛 Thu, 02 Oct 2025 23:37:33 GMT
• is ionis pharmaceuticals inc isi a good long term investment - exit strategy tips & free real-time trading alerts every day earlytimes.in Thu, 02 Oct 2025 15:14:40 GMT
• ionis pharma evp sells $1.6m in ions stock by investing.com Investing.com Australia Thu, 02 Oct 2025 13:21:34 GMT
• Ionis (IONS) Price Target Hiked Following Positive Zilganersen Trial Results Yahoo Finance Thu, 02 Oct 2025 05:35:37 GMT
• Insider Sell: Patrick O'neil Sells 25,300 Shares of Ionis Pharma GuruFocus Wed, 01 Oct 2025 22:24:27 GMT
• Ionis Pharma EVP sells $1.6m in IONS stock By Investing.com Investing.com UK Wed, 01 Oct 2025 21:00:00 GMT
• ionis pharma evp geary sells $3.77m in shares by investing.com Investing.com UK Wed, 01 Oct 2025 21:00:00 GMT
• maxion therapeutics appoints joel edwards as chief business officer The Manila Times Wed, 01 Oct 2025 12:21:38 GMT
• Ionis Pharmaceuticals stock hits 52-week high at 64.89 USD By Investing.com Investing.com Nigeria Wed, 01 Oct 2025 06:37:43 GMT
• what analysts say about ionis pharmaceuticals inc isi stock - dividend stock watch & high return wealth plans earlytimes.in Wed, 01 Oct 2025 01:55:44 GMT
• ionis pharmaceuticals stock hits 52-week high at 64.89 usd by investing.com Investing.com Canada Tue, 30 Sep 2025 15:32:35 GMT
• u.s. transthyretin amyloidosis treatment market to witness openPR.com Tue, 30 Sep 2025 13:31:01 GMT
• Alnylam and Ionis Pharmaceuticals are the leading companies openPR.com Tue, 30 Sep 2025 12:16:10 GMT
• applying big data sentiment scoring on ionis pharmaceuticals inc. - 2025 historical comparison & risk controlled stock pick alerts... newser.com Tue, 30 Sep 2025 09:55:38 GMT
• Ionis Pharmaceuticals reports zilganersen study met primary, secondary endpoints MSN Tue, 30 Sep 2025 07:05:36 GMT
• Should you hold or exit Ionis Pharmaceuticals Inc. now - July 2025 Sector Moves & Verified Stock Trade Ideas newser.com Tue, 30 Sep 2025 07:04:40 GMT
• Ionis Pharmaceuticals: Strategic Advancements and Market Opportunities Amidst Competitive Challenges TipRanks Mon, 29 Sep 2025 11:38:48 GMT
• Is Ionis Pharmaceuticals Inc. (ISI) stock in buy zone after pullback - Weekly Market Summary & Expert-Curated Trade Recommendation... newser.com Mon, 29 Sep 2025 10:22:17 GMT
• why etfs are accumulating ionis pharmaceuticals inc. (isi) stock - portfolio gains report & comprehensive market scan reports newser.com Mon, 29 Sep 2025 09:59:21 GMT
• Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Investor Ratings Indicate Promising Upside Potential DirectorsTalk Interviews Mon, 29 Sep 2025 09:48:39 GMT
• assenagon asset management s.a. purchases new position in ionis pharmaceuticals, inc. $ions MarketBeat Sun, 28 Sep 2025 08:04:06 GMT
• Should you hold or exit Ionis Pharmaceuticals Inc. now - Quarterly Market Review & Real-Time Volume Trigger Notifications newser.com Sun, 28 Sep 2025 05:39:55 GMT
• Using fundamentals and technicals on Ionis Pharmaceuticals Inc. - Trade Volume Report & Risk Controlled Daily Trade Plans newser.com Sun, 28 Sep 2025 05:27:39 GMT
• Is Ionis Pharmaceuticals Inc. (ISI) stock a fit for income portfolios - July 2025 Price Swings & Daily Chart Pattern Signal Report... newser.com Sat, 27 Sep 2025 23:55:03 GMT
• Should you hold or exit Ionis Pharmaceuticals Inc. now - Earnings Overview Report & Technical Pattern Based Signals newser.com Sat, 27 Sep 2025 22:19:53 GMT
• Is Ionis Pharmaceuticals Still Attractive After 85% Rally and ALS Drug Approval? simplywall.st Sat, 27 Sep 2025 19:31:43 GMT
• ionis pharmaceuticals (ions) is up 5.0% after positive phase iii results for alexander disease therapy Yahoo Finance Sat, 27 Sep 2025 14:13:02 GMT
• ions upgraded by goldman sachs with a significant price target i GuruFocus Fri, 26 Sep 2025 17:39:52 GMT
• Is Ionis Pharmaceuticals Inc. (ISI) stock a fit for income portfolios - Weekly Market Report & Accurate Intraday Trading Signals newser.com Fri, 26 Sep 2025 17:09:38 GMT
• u.s. hereditary angioedema market is booming worldwide 2025-2032 | ionis pharmaceuticals, shire (takeda) openPR.com Fri, 26 Sep 2025 12:41:03 GMT
• ionis pharmaceuticals (nasdaq:ions) rating increased to neutral at the goldman sachs group MarketBeat Fri, 26 Sep 2025 12:08:07 GMT
• Ranking Ionis Pharmaceuticals Inc. among high performing stocks via tools - July 2025 Selloffs & Expert-Curated Trade Recommendati... newser.com Fri, 26 Sep 2025 11:16:55 GMT
• goldman sachs upgrades ionis pharmaceuticals to neutral from sell, adjusts pt to $65 from $45 MarketScreener Fri, 26 Sep 2025 10:22:18 GMT
• Goldman Sachs upgrades Ionis Pharmaceuticals stock to Neutral on pipeline potential Investing.com Fri, 26 Sep 2025 10:14:09 GMT
• Ionis Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs TipRanks Fri, 26 Sep 2025 09:38:49 GMT
• treatment-resistant hypertension market is projected to grow openPR.com Wed, 24 Sep 2025 22:34:03 GMT
• leerink partners maintains ionis pharmaceuticals(ions.us) with buy rating, raises target price to $68 富途牛牛 Wed, 24 Sep 2025 14:32:00 GMT
• Ionis Pharmaceuticals stock price target raised to $68 by Leerink Partners Investing.com Wed, 24 Sep 2025 11:04:52 GMT
• is ionis pharmaceuticals inc. meeting your algorithmic filter criteria - 2025 buyback activity & entry point confirmation alerts newser.com Wed, 24 Sep 2025 10:23:15 GMT
• morgan stanley raises ionis pharmaceuticals (ions) price target to $86 | ions stock news GuruFocus Wed, 24 Sep 2025 09:35:55 GMT
• biogen hit with setback in pursuit of high-dose spinraza approval FirstWord Pharma Tue, 23 Sep 2025 23:39:31 GMT
• hereditary angioedema market outlook 2034 – clinical trials, market size, medication, prevalence, companies by delveinsight Barchart.com Tue, 23 Sep 2025 22:44:06 GMT
• Ionis Pharmaceuticals Larger Than S&P 500 Component Align Technology Nasdaq Tue, 23 Sep 2025 21:13:00 GMT
• biogen provides regulatory update on high dose regimen of nusinersen Biogen Tue, 23 Sep 2025 20:32:41 GMT
• morgan stanley raises ionis pharmaceuticals (ions) price target to $86 | ions stock news GuruFocus Tue, 23 Sep 2025 18:38:16 GMT
• ions' rare neurological disease drug meets late-stage study goal Nasdaq Tue, 23 Sep 2025 18:15:00 GMT
• ionis plans application submission for zilganersen as potential first treatment for alexander disease following positive data | ne... NeurologyLive Tue, 23 Sep 2025 17:15:06 GMT
• Ionis Pharma’s Drug for Rare Disease With No Approved Therapies Meets Goals of Pivotal Study MedCity News Tue, 23 Sep 2025 16:48:25 GMT
• barclays maintains overweight rating on ions, raises price targe GuruFocus Tue, 23 Sep 2025 14:46:51 GMT
• guggenheim raises ionis pharmaceuticals (ions) price target to $92 | ions stock news GuruFocus Tue, 23 Sep 2025 13:48:44 GMT
• ionis pharmaceuticals (ions): analyst rating update and target p GuruFocus Tue, 23 Sep 2025 13:27:08 GMT
• guggenheim forecasts strong price appreciation for ionis pharmaceuticals (nasdaq:ions) stock MarketBeat Tue, 23 Sep 2025 13:14:33 GMT
• ionis pharmaceuticals (nasdaq:ions) price target raised to $83.00 at bank of america MarketBeat Tue, 23 Sep 2025 12:42:40 GMT
• ionis pharmaceuticals (nasdaq:ions) receives "buy" rating from hc wainwright MarketBeat Tue, 23 Sep 2025 12:33:40 GMT
• ionis heads to fda as antisense therapy aces pivotal study in rare neurological disease BioSpace Tue, 23 Sep 2025 12:08:07 GMT
• ions: hc wainwright reiterates buy rating with $95 target | ions stock news GuruFocus Tue, 23 Sep 2025 11:52:15 GMT
• ionis pharmaceuticals price target raised to $92 from $90 at guggenheim TipRanks Tue, 23 Sep 2025 11:09:28 GMT
• buy rating for ionis pharmaceuticals: promising phase 3 results for zilganersen in alexander disease TipRanks Tue, 23 Sep 2025 10:14:52 GMT
• ionis reports positive results for alexander disease drug zilganersen by investing.com Investing.com Nigeria Tue, 23 Sep 2025 09:30:34 GMT
• ionis announces positive topline results from pivotal study of zilganersen in alexander disease BioSpace Tue, 23 Sep 2025 07:55:25 GMT
• A Look at Ionis Pharmaceuticals’s Valuation as Zilganersen Delivers Breakthrough Results in Alexander Disease simplywall.st Tue, 23 Sep 2025 07:00:00 GMT
• H.C. Wainwright reiterates Buy rating on Ionis Pharmaceuticals stock Investing.com Tue, 23 Sep 2025 07:00:00 GMT
• Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease Stocktwits Tue, 23 Sep 2025 07:00:00 GMT
• guggenheim raises ionis pharmaceuticals stock price target on positive trial data Investing.com Tue, 23 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals price target raised to $80 from $78 at barclays TipRanks Tue, 23 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals price target raised to $83 from $81 at bofa TipRanks Tue, 23 Sep 2025 07:00:00 GMT
• ionis' rare neurological disorder drug shows promise in clinical trial ET Pharma Tue, 23 Sep 2025 01:30:15 GMT
• ionis pharmaceuticals, inc. $ions shares sold by sovran advisors llc MarketBeat Mon, 22 Sep 2025 23:14:41 GMT
• buy rating affirmed for ionis pharmaceuticals amid promising phase iii results for zilganersen in treating alexander disease TipRanks Mon, 22 Sep 2025 22:32:39 GMT
• zilganersen demonstrates stabilization of gait speed for alexander disease contemporarypediatrics.com Mon, 22 Sep 2025 20:46:59 GMT
• ionis targets ultra-rare disease market with zilganersen insights.citeline.com Mon, 22 Sep 2025 20:38:03 GMT
• ionis preps alexander disease submission after study win FirstWord Pharma Mon, 22 Sep 2025 16:41:15 GMT
• ionis stock surges after positive results from alexander disease drug Investing.com Mon, 22 Sep 2025 13:25:27 GMT
• ionis reports promising data from study of alexander disease therapy Seeking Alpha Mon, 22 Sep 2025 13:09:41 GMT
• Ionis Pharmaceuticals Reveals 'Unprecedented Results' From Rare Neurological Disease Trial Benzinga Mon, 22 Sep 2025 13:06:58 GMT
• ionis pharmaceuticals price target raised to $75 from $68 at raymond james TipRanks Mon, 22 Sep 2025 12:53:44 GMT
• hereditary angioedema market dynamics indicate upward trajectory through 2034, reports delveinsight openPR.com Mon, 22 Sep 2025 12:38:49 GMT
• raymond james maintains ionis pharmaceuticals(ions.us) with buy rating, raises target price to $75 富途牛牛 Mon, 22 Sep 2025 12:32:00 GMT
• ionis pharmaceuticals (ions) reveals promising results for zilga GuruFocus Mon, 22 Sep 2025 12:11:21 GMT
• ionis pharmaceuticals stock gets eu approval for tryngolza, h.c. wainwright maintains buy Investing.com Mon, 22 Sep 2025 11:49:12 GMT
• ionis reports positive results for alexander disease drug zilganersen Investing.com Mon, 22 Sep 2025 11:22:05 GMT
• ionis' brain disorder drug shows promise in clinical trial TradingView Mon, 22 Sep 2025 11:15:15 GMT
• eu approves tryngolza for treatment of familial chylomicronemia syndrome in adults geneonline.com Mon, 22 Sep 2025 10:49:03 GMT
• Applying big data sentiment scoring on Ionis Pharmaceuticals Inc. - Weekly Stock Recap & Weekly Return Optimization Alerts newser.com Mon, 22 Sep 2025 10:39:54 GMT
• Ionis and Sobi’s Tryngolza gains approval in EU for FCS treatment Pharmaceutical Technology Mon, 22 Sep 2025 10:05:20 GMT
• wedmont private capital acquires new shares in ionis pharmaceuticals, inc. $ions MarketBeat Mon, 22 Sep 2025 08:21:22 GMT
• wedmont private capital purchases shares of 5,282 ionis pharmaceuticals, inc. $ions MarketBeat Mon, 22 Sep 2025 08:21:22 GMT
• tryngolza® (olezarsen) approved in the european union for familial chylomicronemia syndrome (fcs) BioSpace Mon, 22 Sep 2025 07:55:28 GMT
• Ionis plots FDA filing after rare neurological disease candidate posts phase 3 win Fierce Biotech Mon, 22 Sep 2025 07:00:00 GMT
• Ionis announces positive topline results from pivotal study of zilganersen in Alexander disease Business Wire Mon, 22 Sep 2025 07:00:00 GMT
• Ionis Pharma Reports Positive Topline Results From Pivotal Study Of Zilganersen In Alexander Disease Nasdaq Mon, 22 Sep 2025 07:00:00 GMT
• Ionis Pharmaceuticals Reports Positive Study Results for Zilganersen TipRanks Mon, 22 Sep 2025 07:00:00 GMT
• Ionis says RNA drug for rare brain disorder succeeded pivotal trial, plans to ask for FDA approval Endpoints News Mon, 22 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals: strategic positioning and growth potential with olezarsen’s eu approval and promising shtg market prospects... TipRanks Mon, 22 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals reports zilganersen study met primary, secondary endpoints TipRanks Mon, 22 Sep 2025 07:00:00 GMT
• sovran advisors llc decreases stock holdings in ionis pharmaceuticals, inc. $ions MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
• Will FDA Breakthrough Therapy Status for ION582 Redefine Ionis Pharmaceuticals' (IONS) Rare Disease Strategy? Sahm Sun, 21 Sep 2025 17:37:30 GMT
• about us - great american insurance group - specialty property & casualty insurance FinancialContent Sun, 21 Sep 2025 07:53:05 GMT
• stop loss: does ionis pharmaceuticals inc stock have upside surprise potential خودرو بانک Sun, 21 Sep 2025 06:33:09 GMT
• levels update: what are ionis pharmaceuticals incs earnings expectations - earnings overview summary & accurate buy signal alerts خودرو بانک Sun, 21 Sep 2025 06:29:05 GMT
• risk off: will ionis pharmaceuticals inc stock recover after earnings - july 2025 opening moves & free fast entry momentum trade a... خودرو بانک Sat, 20 Sep 2025 09:13:26 GMT
• insider selling: ionis pharmaceuticals (nasdaq:ions) evp sells 1,700 shares of stock MarketBeat Sat, 20 Sep 2025 07:00:00 GMT
• levels update: can ionis pharmaceuticals inc sustain its profitability - july 2025 patterns & high conviction investment ideas khodrobank.com Sat, 20 Sep 2025 03:18:48 GMT
• can ionis pharmaceuticals inc sustain its profitability - july 2025 patterns & high conviction investment ideas خودرو بانک Sat, 20 Sep 2025 03:18:43 GMT
• analysts set ionis pharmaceuticals, inc. (nasdaq:ions) pt at $67.88 MarketBeat Sat, 20 Sep 2025 02:29:33 GMT
• will ionis pharmaceuticals inc benefit from sector rotation - weekly stock summary & long-term capital growth ideas خودرو بانک Sat, 20 Sep 2025 02:20:05 GMT
• levels update: can ionis pharmaceuticals inc sustain its profitability - july 2025 patterns & high conviction investment ideas khodrobank.com Fri, 19 Sep 2025 21:18:24 GMT
• kalvista, ionis/sobi among latest to win eu nod for rare disease drugs Seeking Alpha Fri, 19 Sep 2025 13:36:40 GMT
• kalvista, ionis/sobi win eu nod for drugs (kalv:nasdaq) Seeking Alpha Fri, 19 Sep 2025 13:36:40 GMT
• fda delivers three new hae drugs after four-year drought The Pharma Letter Fri, 19 Sep 2025 12:55:36 GMT
• sobi and ionis win eu approval for tryngolza in fcs The Pharma Letter Fri, 19 Sep 2025 11:00:53 GMT
• tryngolza® (olezarsen) approved in the european union for familial chylomicronemia syndrome (fcs) Yahoo Finance Fri, 19 Sep 2025 11:00:00 GMT
• sobi's tryngolza earns eu approval for rare inherited lipid disorder FirstWord Pharma Fri, 19 Sep 2025 10:52:30 GMT
• sobi’s tryngolza earns eu approval for rare inherited lipid disorder FirstWord Pharma Fri, 19 Sep 2025 10:51:07 GMT
• ionis pharmaceuticals, inc. $ions holdings lowered by sovran advisors llc MarketBeat Fri, 19 Sep 2025 09:28:44 GMT
• ionis pharmaceuticals, inc. $ions is sovran advisors llc's 10th largest position MarketBeat Fri, 19 Sep 2025 09:28:44 GMT
• tryngolza olezarsen approved in eu for treating familial chylomicronemia syndrome geneonline.com Fri, 19 Sep 2025 07:03:09 GMT
• ionis pharmaceuticals, inc. (nasdaq:ions) given average rating of "moderate buy" by brokerages MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals (ions) secures eu approval for tryngolza GuruFocus Fri, 19 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals (nasdaq:ions) evp patrick r. o'neil sells 1,700 shares MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
• tryngolza (olezarsen) approved in the european union for familial chylomicronemia syndrome (fcs) 富途牛牛 Fri, 19 Sep 2025 06:20:00 GMT
• update recap: can ionis pharmaceuticals inc weather a recession - breakout watch & community consensus trade alerts خودرو بانک Fri, 19 Sep 2025 02:30:41 GMT
• update recap: can ionis pharmaceuticals inc weather a recession - breakout watch & community consensus trade alerts khodrobank.com Thu, 18 Sep 2025 20:35:35 GMT
• surf away+ event brings fun in the sun to people with rare diseases ALS News Today Thu, 18 Sep 2025 12:43:46 GMT
• what is leerink partnrs' forecast for ions fy2025 earnings? MarketBeat Thu, 18 Sep 2025 10:56:04 GMT
• analysts set ionis pharmaceuticals, inc. (nasdaq:ions) price target at $67.88 MarketBeat Thu, 18 Sep 2025 09:14:23 GMT
• Ionis Pharmaceuticals’ SWOT analysis: stock outlook amid pipeline progress Investing.com Thu, 18 Sep 2025 07:00:00 GMT
• quarterly recap: does ionis pharmaceuticals inc have consistent dividend growth - 2025 volume leaders & reliable price breakout si... خودرو بانک Thu, 18 Sep 2025 06:47:31 GMT
• ionis pharmaceuticals (ions) q2 earnings and revenues beat estimates MSN Thu, 18 Sep 2025 06:08:45 GMT
• ionis gets fda breakthrough therapy status for angelman syndrome drug MSN Wed, 17 Sep 2025 22:58:40 GMT
• ionis pharmaceuticals (nasdaq:ions) evp sells $109,786.00 in stock MarketBeat Wed, 17 Sep 2025 21:49:57 GMT
• ionis pharmaceuticals (nasdaq:ions) evp patrick r. o'neil sells 1,700 shares MarketBeat Wed, 17 Sep 2025 21:49:57 GMT
• insider sell: patrick o'neil sells 1,700 shares of ionis pharmaceuticals inc (ions) GuruFocus Tue, 16 Sep 2025 22:17:05 GMT
• market trends: is ionis pharmaceuticals inc. stock trending bullish - breakout watch & entry point confirmation signals khodrobank.com Tue, 16 Sep 2025 16:30:14 GMT
• ionis pharmaceuticals (nasdaq:ions) evp patrick r. o'neil sells 21,000 shares MarketBeat Tue, 16 Sep 2025 16:04:35 GMT
• volume report: is ionis pharmaceuticals inc. a cyclical or defensive stock - july 2025 retail & ai enhanced trading signals خودرو بانک Tue, 16 Sep 2025 14:56:25 GMT
• meme stocks: will ionis pharmaceuticals inc. stock recover after earnings - 2025 institutional moves & ai optimized trading strate... khodrobank.com Tue, 16 Sep 2025 12:35:34 GMT
• sectors review: is ionis pharmaceuticals inc. exposed to political risk - portfolio value summary & verified short-term plans khodrobank.com Tue, 16 Sep 2025 10:16:16 GMT
• new drug could be first to stop deadly fatty liver disease ScienceDaily Tue, 16 Sep 2025 09:03:54 GMT
• ionis pharmaceuticals targets $750m revenue for 2025 with multiple launches underway MSN Tue, 16 Sep 2025 07:14:22 GMT
• ionis pharmaceuticals (nasdaq:ions) evp sells $1,355,760.00 in stock MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals, inc. (nasdaq:ions) receives consensus rating of "moderate buy" from brokerages MarketBeat Tue, 16 Sep 2025 06:39:28 GMT
• brokerages set ionis pharmaceuticals, inc. (nasdaq:ions) pt at $67.88 MarketBeat Tue, 16 Sep 2025 06:39:28 GMT
• aug mood: will ionis pharmaceuticals inc stock recover after earnings - 2025 volatility report & long hold capital preservation ti... خودرو بانک Tue, 16 Sep 2025 04:05:42 GMT
• insider selling: ionis pharmaceuticals (nasdaq:ions) evp sells 21,000 shares of stock MarketBeat Tue, 16 Sep 2025 03:21:40 GMT
• ions up on fda's breakthrough tag for ion582 in angelman syndrome MSN Mon, 15 Sep 2025 20:11:09 GMT
• ionis pharmaceuticals targets $750m revenue for 2025 with multiple launches underway MSN Mon, 15 Sep 2025 19:42:21 GMT
• aug gainers: is ionis pharmaceuticals inc. forming a double bottom - july 2025 market mood & reliable intraday trade plans خودرو بانک Mon, 15 Sep 2025 14:16:03 GMT
• portfolio shifts: is ionis pharmaceuticals inc. stock a good pick for beginners - 2025 big picture & consistent growth stock picks... خودرو بانک Mon, 15 Sep 2025 12:29:35 GMT
• pullback watch: can ionis pharmaceuticals inc be recession proof - weekly stock recap & safe entry zone identification خودرو بانک Mon, 15 Sep 2025 11:34:20 GMT
• is ionis pharmaceuticals inc. exposed to political risk - july 2025 momentum & high return stock watch alerts خودرو بانک Mon, 15 Sep 2025 11:22:44 GMT
• weekly trades: why is ionis pharmaceuticals inc stock going up - 2025 market overview & fast gain stock trading tips خودرو بانک Mon, 15 Sep 2025 09:27:42 GMT
• ionis pharmaceuticals (nasdaq:ions) sets new 12-month high - what's next? MarketBeat Mon, 15 Sep 2025 08:54:54 GMT
• exome asset management llc has $4.09 million stake in ionis pharmaceuticals, inc. $ions MarketBeat Mon, 15 Sep 2025 01:27:09 GMT
• ionis pharmaceuticals targets $750m revenue for 2025 with multiple launches underway MSN Sun, 14 Sep 2025 22:19:52 GMT
• ionis shares jump after drug lowers blood fat levels in advanced trials MSN Sun, 14 Sep 2025 13:16:07 GMT
• ionis pharmaceuticals, inc. $ions is exome asset management llc's 6th largest position MarketBeat Sun, 14 Sep 2025 09:46:06 GMT
• arrowhead files complaint for declaratory judgment against ionis MSN Sun, 14 Sep 2025 08:03:30 GMT
• ionis pharmaceuticals (nasdaq:ions) hits new 52-week high - should you buy? MarketBeat Sun, 14 Sep 2025 07:39:05 GMT
• exome asset management llc has $4.09 million holdings in ionis pharmaceuticals, inc. $ions MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals (nasdaq:ions) evp c frank bennett sells 6,000 shares MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals (nasdaq:ions) sets new 12-month high - what's next? MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals (nasdaq:ions) evp patrick o'neil sells 21,000 shares MarketBeat Sat, 13 Sep 2025 21:46:56 GMT
• drug company, patients bond riding the surf. ‘i just like to feel the wind in my face, too.’ San Diego Union-Tribune Sat, 13 Sep 2025 02:03:45 GMT
• glaxosmithkline declines option on ionis' experimental ttr amyloidosis therapy inotersen FirstWord Pharma Fri, 12 Sep 2025 14:00:58 GMT
• 200+ rare disease patients to join ionis' expanded surf away+ event: from sma-only to 4 communities Stock Titan Fri, 12 Sep 2025 11:00:00 GMT
• takeda poaches top lilly exec; maze soars on early pku drug data Yahoo Finance Fri, 12 Sep 2025 10:45:00 GMT
• ionis expands surf away+ event, marking 10 years of creating unique adaptive experiences for people with neurological diseases Business Wire Fri, 12 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals celebrates 10 years of adaptive event for rare diseases Investing.com Fri, 12 Sep 2025 07:00:00 GMT
• ionis gets fda breakthrough therapy status for angelman syndrome drug MSN Fri, 12 Sep 2025 02:39:00 GMT
• insider selling: ionis pharmaceuticals (nasdaq:ions) evp sells 6,000 shares of stock MarketBeat Fri, 12 Sep 2025 00:59:32 GMT
• raymond james financial inc. boosts stock position in ionis pharmaceuticals, inc. $ions MarketBeat Thu, 11 Sep 2025 21:29:09 GMT
• arrowhead, ionis sue each other over rare fat disorder drugs (2) Bloomberg Law News Thu, 11 Sep 2025 18:19:00 GMT
• arrowhead sues ionis over patent dispute related to lead asset Seeking Alpha Thu, 11 Sep 2025 15:11:08 GMT
• arrowhead sues ionis over patent dispute (arwr:nasdaq) Seeking Alpha Thu, 11 Sep 2025 15:11:08 GMT
• why ionis pharmaceuticals (ions) is up 7.8% after fda breakthrough for ion582 and positive phase 3 data Sahm Thu, 11 Sep 2025 14:37:30 GMT
• ionis pharmaceuticals (nasdaq:ions) reaches new 1-year high - what's next? MarketBeat Thu, 11 Sep 2025 14:28:21 GMT
• ionis pharmaceuticals (nasdaq:ions) sets new 1-year high - still a buy? MarketBeat Thu, 11 Sep 2025 14:28:21 GMT
• patent battle: arrowhead pharmaceuticals fights for revolutionary fcs treatment against ionis claims Stock Titan Thu, 11 Sep 2025 11:30:00 GMT
• edmond de rothschild holding s.a. takes position in ionis pharmaceuticals, inc. $ions MarketBeat Thu, 11 Sep 2025 10:51:05 GMT
• exome asset management llc grows holdings in ionis pharmaceuticals, inc. $ions MarketBeat Thu, 11 Sep 2025 10:11:06 GMT
• ionis pharmaceuticals, inc. $ions stock holdings raised by exome asset management llc MarketBeat Thu, 11 Sep 2025 10:11:06 GMT
• exome asset management llc buys 74,249 shares of ionis pharmaceuticals, inc. $ions MarketBeat Thu, 11 Sep 2025 10:11:06 GMT
• Arrowhead battles Ionis over patent dispute tied to RNAi candidate that could rival Tryngolza Fierce Biotech Thu, 11 Sep 2025 07:00:00 GMT
• Ionis, Arrowhead file dueling patent lawsuits over genetic-disorder drug Reuters Thu, 11 Sep 2025 07:00:00 GMT
• Arrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis Pharmaceuticals Business Wire Thu, 11 Sep 2025 07:00:00 GMT
• raymond james financial inc. grows position in ionis pharmaceuticals, inc. $ions MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals price target raised to $70 from $65 at h.c. wainwright MSN Thu, 11 Sep 2025 06:57:34 GMT
• ionis stock: renewed assault on $100.00 per share (nasdaq:ions) Seeking Alpha Thu, 11 Sep 2025 06:14:47 GMT
• adage capital partners gp l.l.c. purchases 800,600 shares of ionis pharmaceuticals, inc. $ions MarketBeat Thu, 11 Sep 2025 01:39:06 GMT
• ionis pharmaceuticals (ions) q2 earnings and revenues beat estimates MSN Thu, 11 Sep 2025 00:55:42 GMT
• raymond james financial inc. grows holdings in ionis pharmaceuticals, inc. $ions MarketBeat Wed, 10 Sep 2025 22:32:21 GMT
• ions up on fda's breakthrough tag for ion582 in angelman syndrome Yahoo Finance Wed, 10 Sep 2025 15:11:00 GMT
• fda grants breakthrough therapy status to ionis ion582 to treat angelman syndrome Pharmaceutical Business review - Wed, 10 Sep 2025 14:26:15 GMT
• arrowhead files complaint for declaratory judgment against ionis TipRanks Wed, 10 Sep 2025 11:36:29 GMT
• ionis pharmaceuticals to expedite development of rare neurological disease candidate with fda breakthrough status Sahm Wed, 10 Sep 2025 08:21:23 GMT
• adage capital partners gp l.l.c. purchases 800,600 shares of ionis pharmaceuticals, inc. $ions MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
• edmond de rothschild holding s.a. takes position in ionis pharmaceuticals, inc. $ions MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
• royal bank of canada forecasts strong price appreciation for ionis pharmaceuticals (nasdaq:ions) stock MarketBeat Wed, 10 Sep 2025 05:53:18 GMT
• fda grants breakthrough therapy designation to ionis (ions) drug GuruFocus Tue, 09 Sep 2025 21:04:44 GMT
• william blair maintains ionis pharmaceuticals(ions.us) with buy rating 富途牛牛 Tue, 09 Sep 2025 19:29:31 GMT
• aug volume: can ionis pharmaceuticals inc. be recession proof - market rally & capital efficiency focused ideas Lancaster City Council Tue, 09 Sep 2025 18:42:47 GMT
• ionis pharmaceuticals: buy rating backed by breakthrough therapy designation and promising clinical results for ion582 TipRanks Tue, 09 Sep 2025 16:49:37 GMT
• ionis pharmaceuticals granted breakthrough therapy designation to ion582 TipRanks Tue, 09 Sep 2025 16:18:07 GMT
• ionis pharmaceuticals says us fda grants ion582 orphan drug designation to treat rate neurological disease 富途牛牛 Tue, 09 Sep 2025 11:41:59 GMT
• fda grants breakthrough therapy status to ionis pharmaceuticals' ion582 GuruFocus Tue, 09 Sep 2025 11:23:51 GMT
• fda grants breakthrough therapy status to ionis’ angelman syndrome drug Investing.com Tue, 09 Sep 2025 11:13:34 GMT
• first potential treatment for angelman syndrome: ionis' ion582 gains fda breakthrough status Stock Titan Tue, 09 Sep 2025 11:00:00 GMT
• rbc capital sticks to their buy rating for ionis pharmaceuticals (ions) The Globe and Mail Tue, 09 Sep 2025 10:54:00 GMT
• ionis pharmaceuticals (nasdaq:ions) sees strong trading volume on analyst upgrade MarketBeat Tue, 09 Sep 2025 08:17:53 GMT
• ionis rare neurological disease candidate receives fda breakthrough status - ionis pharmaceuticals (nasdaq:ions) Benzinga Tue, 09 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals to expedite development of rare neurological disease candidate with fda breakthrough status Benzinga Tue, 09 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals at morgan stanley conference: strategic growth and innovation Investing.com Tue, 09 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals stock hits 52-week high at 62.28 usd Investing.com Tue, 09 Sep 2025 07:00:00 GMT
• ionis pharmaceuticals (ions): exploring valuation as shares gain momentum without major news simplywall.st Tue, 09 Sep 2025 07:00:00 GMT
• ionis receives u.s. fda breakthrough therapy designation for ion582 in angelman syndrome Business Wire Tue, 09 Sep 2025 07:00:00 GMT
Ionis Pharmaceuticals, Inc(NASDAQ:IONS) 
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis...
Website: http://www.ionispharma.com
Founded: 1989
Full Time Employees: 817
Sector: Healthcare
Industry: Biotechnology